Clinical trial
Vinflunine and Capecitabine in Treating Patients With Previously Treated…
NCT00450515 · Alliance for Clinical Trials in Oncology, Other · Withdrawn
Key facts
| NCT number | NCT00450515 |
|---|---|
| Title | Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast Cancer |
| Official title | Phase II Trial of Vinfluinine and Capecitabine in Previously Treated Metastatic Breast Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | capecitabine, vinflunine |
| Enrollment | 0 |
| Start date | Mar 1, 2007 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Mar 22, 2007 |
| Last update posted | Dec 6, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: